1. Home
  2. DNA vs BXC Comparison

DNA vs BXC Comparison

Compare DNA & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • BXC
  • Stock Information
  • Founded
  • DNA 2008
  • BXC 2004
  • Country
  • DNA United States
  • BXC United States
  • Employees
  • DNA N/A
  • BXC N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • BXC Wholesale Distributors
  • Sector
  • DNA Health Care
  • BXC Consumer Discretionary
  • Exchange
  • DNA Nasdaq
  • BXC Nasdaq
  • Market Cap
  • DNA 552.0M
  • BXC 551.4M
  • IPO Year
  • DNA N/A
  • BXC 2004
  • Fundamental
  • Price
  • DNA $12.85
  • BXC $73.69
  • Analyst Decision
  • DNA Hold
  • BXC Strong Buy
  • Analyst Count
  • DNA 2
  • BXC 3
  • Target Price
  • DNA $8.50
  • BXC $91.00
  • AVG Volume (30 Days)
  • DNA 1.7M
  • BXC 150.4K
  • Earning Date
  • DNA 08-07-2025
  • BXC 07-29-2025
  • Dividend Yield
  • DNA N/A
  • BXC N/A
  • EPS Growth
  • DNA N/A
  • BXC N/A
  • EPS
  • DNA N/A
  • BXC 3.42
  • Revenue
  • DNA $237,417,000.00
  • BXC $2,947,258,000.00
  • Revenue This Year
  • DNA N/A
  • BXC $2.76
  • Revenue Next Year
  • DNA $15.91
  • BXC $4.81
  • P/E Ratio
  • DNA N/A
  • BXC $21.63
  • Revenue Growth
  • DNA 13.76
  • BXC N/A
  • 52 Week Low
  • DNA $5.00
  • BXC $63.14
  • 52 Week High
  • DNA $16.85
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • DNA 58.06
  • BXC 45.88
  • Support Level
  • DNA $11.75
  • BXC $69.98
  • Resistance Level
  • DNA $14.28
  • BXC $75.29
  • Average True Range (ATR)
  • DNA 1.22
  • BXC 3.16
  • MACD
  • DNA -0.05
  • BXC -0.65
  • Stochastic Oscillator
  • DNA 51.67
  • BXC 42.46

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: